Haemonetics Corp (HAE) - Financial and Strategic SWOT Analysis Review

June 2021 | 59 pages | ID: HF2FD737A14EN
GlobalData

Abstracts

Haemonetics Corp (HAE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Haemonetics Corp (Haemonetics) is a healthcare company that offers blood management technologies and software solutions. The company's portfolio includes integrated devices, information management software, and consulting services for improving clinical outcomes. It also offers a comprehensive suite of solutions to the blood supply chain, which ranges from plasma and blood collectors to hospitals. Haemonetics markets its products to blood collection groups and independent blood centers, national health organizations, hospital service providers, hospitals, group purchasing organizations, and biopharmaceutical companies through a direct sales force and independent distributors. It has subsidiaries in the Americas, Asia and Europe. Haemonetics is headquartered in Boston, Massachusetts, the US.

Haemonetics Corp Key Recent Developments

May 21,2021: HAEMONETICS: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
May 13,2021: Haemonetics 4th Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website
Apr 23,2021: Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2021 Results: May 13, 2021
Feb 26,2021: Haemonetics To Present At The Jefferies Plasma Summit
Feb 02,2021: Haemonetics 3rd Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Haemonetics Corp - Key Facts
Haemonetics Corp - Key Employees
Haemonetics Corp - Key Employee Biographies
Haemonetics Corp - Major Products and Services
Haemonetics Corp - History
Haemonetics Corp - Company Statement
Haemonetics Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Haemonetics Corp - Business Description
Product Category: Blood Center
Overview
Performance
Product Category: Hospital
Overview
Performance
Product Category: Plasma
Overview
Performance
Product Category: Service
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Other
Performance
Geographical Segment: The US
Performance
R&D Overview
Haemonetics Corp - Corporate Strategy
Haemonetics Corp - SWOT Analysis
SWOT Analysis - Overview
Haemonetics Corp - Strengths
Haemonetics Corp - Weaknesses
Haemonetics Corp - Opportunities
Haemonetics Corp - Threats
Haemonetics Corp - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Haemonetics Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Haemonetics Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Haemonetics Corp, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 21, 2021: HAEMONETICS: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
May 13, 2021: Haemonetics 4th Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website
Apr 23, 2021: Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2021 Results: May 13, 2021
Feb 26, 2021: Haemonetics To Present At The Jefferies Plasma Summit
Feb 02, 2021: Haemonetics 3rd Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website
Sep 18, 2020: Haemonetics: Regulation FD Disclosure
Jul 27, 2020: Ab?nex to acquire Haemonetics’ subsidiary Inlog Holdings France
Jul 02, 2020: Haemonetics statement on the safety of our blood and plasma collection devices
May 05, 2020: Haemonetics reports 4 th quarter and fiscal 2020 results; provides update on business continuity and impacts from COVID-19
Apr 17, 2020: Michael Coyle joins Haemonetics board of directors

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Haemonetics Corp, Key Facts
Haemonetics Corp, Key Employees
Haemonetics Corp, Key Employee Biographies
Haemonetics Corp, Major Products and Services
Haemonetics Corp, History
Haemonetics Corp, Other Locations
Haemonetics Corp, Subsidiaries
Haemonetics Corp, Key Competitors
Haemonetics Corp, Ratios based on current share price
Haemonetics Corp, Annual Ratios
Haemonetics Corp, Annual Ratios (Cont...1)
Haemonetics Corp, Annual Ratios (Cont...2)
Haemonetics Corp, Interim Ratios
Haemonetics Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Haemonetics Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Haemonetics Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Haemonetics Corp, Performance Chart (2017 - 2021)
Haemonetics Corp, Ratio Charts
Haemonetics Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Haemonetics Corp, Medical Equipment, Deals by Type, 2015 to YTD 2021